Request Deal Involvement
Apexigen went public via a SPAC merger with Brookline Capital Acquisition in a $205m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Ladenburg Thalmann
financial advisors
Brookline Capital
legal advisors
DLA Piper
legal advisors
Wilson Sonsini Goodrich & Rosati
financial advisors
Wedbush PacGrow
or
Principals
bidder
BROOKLINE CAPITAL ACQUISITION CORP
target
APEXIGEN
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite